A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors
A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors
Recruiting · NCT07328217 · Registry updated 2026-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-02-11 | NCT07328217 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dizal Pharmaceuticals | 20 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 55 |
| Beijing Chest Hospital, Capital Medical University | Beijing | China | 6 |
| Peking Union Medical College Hospital | Beijing | China | 48 |